Louise Boyle on Muck Rack

Louise Boyle

Verified
New York
As seen in: The Independent (UK), MSN, MSN Australia, MSN Ireland, MSN Singapore, Daily Mail, Daily Mail Femail, MSN South Africa, MSN UK, Scribd, Yahoo Canada and
US Deputy News Editor, former Senior Climate Correspondent for @Independent. Tips: l.boyle@the-independent.com
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Louise

Contact Louise, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Major retailer to offer weight-loss jabs at discounted price

|
By Louise Boyle Verified
| Inkl
Get all your news in one place. Get all your news in one place. 100’s of premium titles. One news app. Start reading The Independent UK Lifestyle Major retailer to offer weight-loss jabs at discounted price Costco has partnered with Novo Nordisk to offer popular GLP-1 medications, Ozempic and Wegovy, at a discounted price. The drugs will be available for £499 at 600 Costco pharmacies, specifically for members not using insurance.
Open in Who Shared View Duplicates (3) Issue with article?

TAPBPR promotes editing of the HLA-B44 peptide repertoire, increasing the presentation of peptides containing a C-terminal tryptophan

|
By Aure Aflalo, Marcel Wacker, Esam Khanfar, Jens Bauer, Juliane S. Walz, Louise Boyle Verified, Arwen F. Altenburg
| Frontiers in Immunology
1 Introduction Major histocompatibility complex class I (MHC-I) molecules play a crucial role in the adaptive immune response by presenting antigenic peptides typically derived from the intracellular proteome to CD8+ T cells (1, 2). Furthermore, the expression of MHC-I is monitored by natural killer (NK) cells for immunosurveillance (3, 4).
Open in Who Shared Issue with article?

A comparison between hydrocortisone and prednisolone in the treatment of adrenal insufficiency - HYPER-AID study interim results from a tertiary care center

|
By Masato Ahsan, Amy Morrison, Shailesh Gohil, Louise Boyle Verified
| endocrine-abstracts.org
Background: Adrenal insufficiency (AI) is treated with lifelong glucocorticoid replacement historically with Hydrocortisone (2-3 divided doses per day) (1). Prednisolone is an alternative option with longer half-life up to 3.2 hours and requires once daily dosage. Currently there is no clear evidence indicating the superiority of one medication over the other (2).
Open in Who Shared Issue with article?
See all 1,436 licensed articles (3,580 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified